辉瑞与阿里健康共建“偏头痛疾病中心” 创新药瑞美吉泮口崩片首发上线

证券日报03-12

近日，辉瑞旗下全新一代特异性偏头痛治疗药物瑞美吉泮口崩片（商品名：乐泰可）在阿里健康大药房首发上线。该药是全球首个且唯一采用专利口崩片技术的降钙素基因相关肽（CGRP）受体拮抗剂，用于成年人偏头痛急性治疗。偏头痛是临床最常见却又最“难缠”的原发性头痛类型，以发作性中重度、搏动样头痛为主要表现，头痛多为偏侧，一般持续4～72小时。流行病学调查显示，我国18～65岁人群偏头痛年患病率为9.3%，越来越...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2418055589?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-12 18:23","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2418055589","market":"hk","top_or_hot":-1,"title":"辉瑞与阿里健康共建“偏头痛疾病中心” 创新药瑞美吉泮口崩片首发上线","media":"证券日报","content":"<div>\n<p>近日，辉瑞旗下全新一代特异性偏头痛治疗药物瑞美吉泮口崩片（商品名：乐泰可）在阿里健康大药房首发上线。该药是全球首个且唯一采用专利口崩片技术的降钙素基因相关肽（CGRP）受体拮抗剂，用于成年人偏头痛急性治疗。偏头痛是临床最常见却又最“难缠”的原发性头痛类型，以发作性中重度、搏动样头痛为主要表现，头痛多为偏侧，一般持续4～72小时。流行病学调查显示，我国18～65岁人群偏头痛年患病率为9.3%，越来越...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202403123009531025.html\">网页链接</a>\n\n</div>\n","source":"stock_eastmoney","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>辉瑞与阿里健康共建“偏头痛疾病中心” 创新药瑞美吉泮口崩片首发上线</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n辉瑞与阿里健康共建“偏头痛疾病中心” 创新药瑞美吉泮口崩片首发上线\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-12 18:23 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202403123009531025.html><strong>证券日报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，辉瑞旗下全新一代特异性偏头痛治疗药物瑞美吉泮口崩片（商品名：乐泰可）在阿里健康大药房首发上线。该药是全球首个且唯一采用专利口崩片技术的降钙素基因相关肽（CGRP）受体拮抗剂，用于成年人偏头痛急性治疗。偏头痛是临床最常见却又最“难缠”的原发性头痛类型，以发作性中重度、搏动样头痛为主要表现，头痛多为偏侧，一般持续4～72小时。流行病学调查显示，我国18～65岁人群偏头痛年患病率为9.3%，越来越...</p>\n\n<a href=\"http://finance.eastmoney.com/a/202403123009531025.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1501","symbol_name":"阿里概念股","start_time":0,"source_url":"http://finance.eastmoney.com/a/202403123009531025.html","article_id":"2418055589","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2418055589","pubTimestamp":1710238996,"sourceInfo":{"source_id":"stock_eastmoney","name":"东方财富"},"weMediaInfo":null,"summary":"近日，辉瑞旗下全新一代特异性偏头痛治疗药物瑞美吉泮口崩片（商品名：乐泰可）在阿里健康大药房首发上线。该药是全球首个且唯一采用专利口崩片技术的降钙素基因相关肽（CGRP）受体拮抗剂，用于成年人偏头痛急性治疗。偏头痛是临床最常见却又最“难缠”的原发性头痛类型，以发作性中重度、搏动样头痛为主要表现，头痛多为偏侧，一般持续4～72小时。","collect":0,"end_time":0,"defaultTopTitle":"eastmoney.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1501":"阿里概念股","BK1589":"北水核心资产","SG9999011175.SGD":"Nikko AM Global Dividend Equity Dis SGD-H","BK1515":"抗疫概念","BK4585":"ETF&股票定投概念","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","BK1574":"生物医药B类股","SG9999002232.USD":"Allianz Global High Payout USD","LU0234572021.USD":"高盛美国核心股票组合Acc","BK4534":"瑞士信贷持仓","BK1189":"医疗保健技术","BK1247":"药品零售","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4007":"制药","SG9999002224.SGD":"Allianz Global High Payout SGD","LU0058720904.USD":"联博国际健康护理基金A","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","LU1066053197.SGD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM3\" (SGDHDG) INC","BK1571":"互联网医疗","BK4588":"碎股","BK4568":"美国抗疫概念","BK4550":"红杉资本持仓","LU0122379950.USD":"贝莱德世界健康科学A2","LU0868494617.USD":"UBS (LUX) EQUITY SICAV - US TOTAL YIELD SUSTAINABLE \"P\" (USD) ACC","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","06978":"永泰生物-B","BK4592":"伊斯兰概念","BK1161":"生物科技","BK1610":"ETF&股票定投概念","LU1057294990.SGD":"Blackrock World Healthscience A2 SGD-H","IE00B19Z3B42.SGD":"Legg Mason ClearBridge - Value A Acc SGD","SG9999001176.USD":"United Global Healthcare Acc USD","BK4581":"高盛持仓","LU0289739699.SGD":"AB INTERNATIONAL HEALTH CARE PORTFOLIO \"A\" (SGD) ACC","IE00BLSP4452.SGD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis SGD-H Plus","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","SG9999003800.SGD":"Nikko AM Global Dividend Equity Acc SGD-H","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","BK1142":"互联网与直销零售","SGXZ57979304.SGD":"United Global Healthcare A Acc SGD-H","BK1591":"就地过年概念","PFE":"辉瑞","00241":"阿里健康","LU0170899867.USD":"EASTSPRING INVESTMENTS WORLD VALUE EQUITY  \"A\" (USD) ACC","LU0456855351.SGD":"JPMorgan Funds - Global Equity A (acc) SGD","IE00B19Z3581.USD":"Legg Mason ClearBridge - Value A Acc USD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK1502":"双十一","BK1584":"蚂蚁金服概念"},"translate_title":"Pfizer and Ali Health jointly built the \"Migraine Disease Center\", and the innovative drug Remeijiepan Orally Disintegrating Tablets were launched","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06978":1,"00241":1,"PFE":1},"content_text":"近日，辉瑞旗下全新一代特异性偏头痛治疗药物瑞美吉泮口崩片（商品名：乐泰可）在阿里健康大药房首发上线。该药是全球首个且唯一采用专利口崩片技术的降钙素基因相关肽（CGRP）受体拮抗剂，用于成年人偏头痛急性治疗。偏头痛是临床最常见却又最“难缠”的原发性头痛类型，以发作性中重度、搏动样头痛为主要表现，头痛多为偏侧，一般持续4～72小时。流行病学调查显示，我国18～65岁人群偏头痛年患病率为9.3%，越来越多的人饱受偏头痛困扰，面临预防性治疗不充分，有效治疗手段匮乏，以及镇痛药物过度使用等问题。 　　有别于传统治疗方案，此次上市的瑞美吉泮口崩片是通过阻断CGRP配体与受体的结合来发挥其临床效应，能够有效阻断偏头痛发病的关键通路，快速且持续缓解头痛及相关伴随症状。该药也是目前全球唯一在美国FDA和欧盟EMA均获批的，同时具备急性及预防性治疗偏头痛适应症的药物。 　　瑞美吉泮口崩片在中国的关键试验中显示出积极结果，表现出良好的安全性和耐受性。患者可在45分钟内迅速缓解疼痛和消除最困扰的症状，60分钟内恢复正常功能，90分钟内消除疼痛。对多数患者而言，其持续疗效可达48小时。这一创新药物的落地将助力偏头痛疾病的规范化管理，惠及更多偏头痛患者，为其提供治疗新选择。 　　首都医科大学附属北京天坛医院头痛科主任、中华医学会神经内科分会头痛协作组组长、中国卒中学会头痛分会主任委员王永刚教授表示：“以瑞美吉泮为代表的新一代特异性治疗方案为偏头痛的急性治疗带来新的选择。CGRP受体拮抗剂瑞美吉泮在快速缓解偏头痛患者急性发作症状的同时，每月按需服用还可以带来患者头痛发作天数减少的趋势，为偏头痛患者带来双重获益，让他们能够更好地回归工作和生活。” 　　据悉，药品首发上线后，阿里健康将借助遍及全国百城的专业药品仓配体系，让创新治疗方案惠及更多中国患者。辉瑞也将与阿里健康合作共建线上“偏头痛疾病中心”，为患者提供线上诊疗、疾病科普、药品供应、专家咨询等一系列全病程管理服务，帮助偏头痛患者减轻疾病疼痛困扰，提高生活质量。（文章来源：证券日报）","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2418055589"}